Evidence map›Paper›PMID 30214516›Full record

ArticleExperimental and therapeutic medicine2018

Inhibition of RKIP aggravates thioacetamide-induced acute liver failure in mice.

Xing Lin, Jinbin Wei, Jinlan Nie, Facheng Bai, Xunshuai Zhu, Lang Zhuo, Zhongpeng Lu, Quanfang Huang

RetractedAbstract readRetracted Publication
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Xing LinPharmaceutical College and Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Jinbin WeiPharmaceutical College and Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Jinlan NiePharmaceutical College and Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Facheng BaiPharmaceutical College and Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Xunshuai ZhuPharmaceutical College and Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Lang ZhuoDepartment of Bioengineering, Institute of Bioengineering and Nanotechnology, Singapore 169483, Republic of Singapore.
Zhongpeng LuDepartment of Biochemistry, University of Arkansas Medical School, Little Rock, AR 72205-7199, USA.
Quanfang HuangDepartment of Pharmacy, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530023, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence has indicated that Raf kinase inhibitor protein (RKIP) is involved in several intracellular signaling pathways; its abnormal expression is associated with tumor progression and metastasis in several human neoplasms. However, the role of RKIP in acute liver injury has remained elusive. In the present study, acute liver failure was induced by thioacetamide in mice, and locostatin was used to interfere with RKIP expression. It was found that RKIP expression was significantly inhibited by locostatin. Down-regulation of RKIP expression resulted in severe liver injury and extensive release of alanine aminotransferase and aspartate aminotransferase. In addition, reduced RKIP expression significantly enhanced the levels of reactive oxygen species and the content of pro-inflammatory factors such as tumor necrosis factor-α as well as interleukin-6 and -1β, and decreased the levels of nuclear factor E2-related factor-2 and heme oxygenase-1. Furthermore, down-regulation of RKIP promoted the activation of the nuclear factor-κB and extracellular signal-regulated kinase signaling pathways. In conclusion, the present study indicates an inverse correlation between RKIP level and the degree of hepatic injury, that is, a decrease in RKIP expression may exacerbate acute liver failure.

Indexed as

acute liver injuryextracellular signal-regulated pathwaylocostatinnuclear factor-κB pathwayRaf kinase inhibitor protein

Identifiers

PMID30214516
PMCPMC6125827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.